Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Learn the best strategies for using credit card points when shopping online to maximize your savings.
18,914 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
The voting tech firm Smartmatic has filed to dismiss a money laundering indictment, arguing political pressure shaped...
Beachbody's 2025 earnings shed light on how fitness brands monetize digital subscriptions, gear, and licensing. This ...
T-Mobile US leads on postpaid customer growth and cash flow, while Vodafone accelerates cross-border restructuring an...
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
Global markets wobble as Iran-related tensions flare, pushing equities toward correction while traders turn to option...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
Netflix remains the benchmark in streaming, but rivals are accelerating with new pricing, ad tiers, and AI-driven fea...
When a mid-size fund dumps a sizable stake, it sends a signal about risk and opportunity. Kadensa Capital liquidates ...
Palantir stock isn't cheap, but its AI-driven data platform and strong government foothold create a long‑term thesis ...
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Long-term compound growth in tech requires durable moats and disciplined capital allocation. Here are two powerhouse ...